{"abstract": "Novartis is buying the injectable generic cancer drugs business of Austria\u2019s EBEWE Pharma and may pursue other similar deals.", "web_url": "https://dealbook.nytimes.com/2009/05/20/novartis-pays-12-billion-for-cancer-drug-unit/", "snippet": "Novartis is buying the injectable generic cancer drugs business of Austria\u2019s EBEWE Pharma and may pursue other similar deals.", "lead_paragraph": "Novartis is buying the injectable generic cancer drug business of Austria\u2019s Ebewe Pharma and may pursue other similar deals as it fleshes out a planned diversification away from brand-name treatments, Reuters reported.", "source": "The New York Times", "multimedia": [], "headline": {"main": "Novartis Pays $1.2 Billion for Cancer Drug Unit", "kicker": "DealBook", "content_kicker": null, "print_headline": "", "name": null, "seo": null, "sub": null}, "keywords": [], "pub_date": "2009-05-20T11:18:37+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By Dealbook", "person": [{"firstname": "Dealbook", "middlename": null, "lastname": "", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/37ac1efd-88a1-5c57-aece-ec53ebc90b5b", "word_count": 501, "uri": "nyt://article/37ac1efd-88a1-5c57-aece-ec53ebc90b5b"}